References
1. Domanski G., Lange A.E., Ittermann T., Allenberg H., et al. Evaluation of neonatal and maternal morbidity in mothers with gestational diabetes: a population-based study. BMC Pregnancy Childb. 2018; 18 (1): 367. doi: 10.1186/s12884-018-2005-9.
2. Kautzky-Willer A., Harreiter J., Bancher-Todesca D., Berger A., et al. Gestational diabetes mellitus. Wien Klin Wochenschr. 2016; 128 (suppl 2): 103-12. doi: 10.1007/s00508-015-0941-1.
3. Reichelt A.J., Weinert L.S., Mastella L.S., Gnielka V., et al. Clinical characteristics of women with gestational diabetes - comparison of two cohorts enrolled 20 years apart in southern Brazil. Sao Paulo Med. 2017; 135 (4): 376-82. doi: 10.1590/1516-3180.2016.0332190317.
4. Papysheva O., Kotaish G., Mayatskaya T., Sidorova S., et al. Gestational diabetes mellitus in obesity pandemic: pathogenetic features. Vrach [Physician]. 2019; 30 (1): 27-32. doi: 10.29296/25877305-2019-01-04. (in Russian)
5. Sudasinghe B.H., Wijeyaratne C.N., Ginige P.S. Long and short-term outcomes of Gestational Diabetes Mellitus (GDM) among South Asian women - a community-based study. Diabetes Res Clin Pract. 2018; 145: 93-101. doi: 10.1016/j.diabres.2018.04.013.
6. Casey B.M., Rice M.M., Landon M.B., et al. Effect of treatment of mild gestational diabetes on long-term maternal outcomes. Am J Peri-natol. 2019 Mar 13. doi: 10.1055/s-0039-1681058.
7. Karamali M., Dadkhah F., Sadrkhanlou M., Jamillian M., et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab. 2016; 42 (4): 234-41. doi: 10.1016/j.diabet.2016.04.009.
8. Schliefsteiner C., Hirschmugl B., Kopp S., Curcic S., et al. Maternal gestational diabetes mellitus increases placental and foetal lipoprotein-associated phospholipase A2 which might exert protective functions against oxidative stress. Sci Rep. 2017; 7 (1): 12628. doi: 10.1038/s41598-017-13051-6.
9. Gestational diabetes mellitus: diagnosis, treatment, postpartum observation. Clinical guidelines (protocol). Moscow, 2014: 18 p. (Approved by the Ministry of Health of the Russian Federation 17.12.2013 g No. 15-4/10/2-9478). (in Russian)
10. Troshina E.A., Pokusaeva V.N., Andreeva V.N. Obesity in women. In: G.A. Mel'nichenko, N.K. Nikiforovsky (eds). Moscow: Meditsinskoe informat-sionnoe agenstvo, 2017: 272 p. (in Russian)
11. Bashmakova N.V., Derjabina E.G. (eds). Gestational diabetes mellitus. What do we know about him today? Ekaterinburg, 2015: 124 p. (in Russian)
12. Joseph K.S., Lisonkova S., Muraca G.M., Razaz N., et al. Factors underlying the temporal increase in maternal mortality in the United States. Obstet Gynecol. 2017; 129 (1): 91-100. doi: 10.1097/AOG.0000000000001810.
13. Cruz J., Grandia R., Padilla L., et al. Macrosomia predictors in infants born to Cuban mothers with gestational diabetes. MEDICC Rev. 2015; 17 (3): 27-32.
14. Gu S., An X., Fang L., Zhang X., et al. Risk factors and long-term health consequences of macrosomia: a prospective study in Jiangsu Province, China. J Biomed Res. 2012; 26 (4): 235-40.
15. Boriboonhirunsarn D. Second trimester weight gain > 7 kg increases the risk of gestational diabetes after normal first trimester screening. J Obstet Gynaecol Res. 2017; 43 (3): 462-7. doi: 10.1111/jog.13231.
16. Feng Y., Jiang C.D., Chang A.M., Shi Y., et al. Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2019; 32 (2): 339-47. doi: 10.1080/14767058.2018.1446207.
17. Ngala R.A., Fondjo L.A., Gmagna P., Ghartey F.N., et al. Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study. PLoS One. 2017; 12 (7): e0181613. doi: 10.1371/journal.pone.0181613.
18. Kouhkan A., Khamseh M.E., Moini A., Pirjani R., et al. Predictive factors of gestational diabetes in pregnancies following assisted reproductive technology: a nested case-control study. Arch Gynecol Obstet. 2018; 298 (1): 199-206. doi: 10.1007/s00404-018-4772-y.
19. Zipori Y., Lauterbach R., Matanes E., Beloosesky R., et al. Vaginal progesterone for the prevention of preterm birth and the risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2018; 230: 6-9. doi: 10.1016/j.ejogrb.2018.09.011.
20. Nasioudis D., Doulaveris G., Kanninen T.T. Dyslipidemia in pregnancy and maternal-fetal outcome. Minerva Ginecol. 2019; 71 (2): 15562. doi: 10.23736/S0026-4784.18.04330-7.